These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 3544944

  • 1. [Malignant hyperthermia in Austria. I. Epidemiology and clinical aspects].
    Mauritz W, Sporn P, Steinbereithner K.
    Anaesthesist; 1986 Nov; 35(11):639-50. PubMed ID: 3544944
    [Abstract] [Full Text] [Related]

  • 2. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB.
    Anesth Analg; 2010 Feb 01; 110(2):498-507. PubMed ID: 20081135
    [Abstract] [Full Text] [Related]

  • 3. [Regional distribution of predisposition to maligant hyperthermia in Germany: tate in 1997].
    Hartung E, Anetseder M, Olthoff D, Deutrich C, Lehmann-Horn F, Baur C, Mortier W, Tzanova I, Doetsch S, Quasthoff S, Hofmann M, Schwefler B, Jantzen JP, Wappler F, Scholz J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr 01; 33(4):238-43. PubMed ID: 9617422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Apr 01; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 6. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005.
    Rosero EB, Adesanya AO, Timaran CH, Joshi GP.
    Anesthesiology; 2009 Jan 01; 110(1):89-94. PubMed ID: 19104175
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov 01; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 12. Malignant hyperthermia susceptibility confirmed in both parents of probands. A report of three Austrian families.
    Mauritz W, Sporn P, Steinbereithner K.
    Acta Anaesthesiol Scand; 1988 Jan 01; 32(1):24-6. PubMed ID: 3344604
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia].
    Ferrari F, D'Alessandro S, Pietrandrea G, Villani A.
    Minerva Anestesiol; 1997 Oct 01; 63(10):311-4. PubMed ID: 9567608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Diagnosis of disposition for malignant hyperthermia--an updated review based on 1,001 studies].
    Olthoff D, Deutrich C, Meinecke CD.
    Anaesthesiol Reanim; 1997 Oct 01; 22(2):32-40. PubMed ID: 9235003
    [Abstract] [Full Text] [Related]

  • 19. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Apr 01; 414():1-284. PubMed ID: 12616284
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.